SUBSCRIBE
SUBSCRIBE
News   Drug Development

Mesoblast Limited Disc Repair Results Highlighted At Key Orthopaedic Conference

September 15, 2009 | 
1 min read
Melbourne, Sep 15, 2009 (ABN Newswire) - Mesoblast Limited's (ASX:MSB)(PINK:MBLTY) successful preclinical disc repair trial was featured at the World Congress on Osteoarthritis held in Montreal, Canada, over the weekend.
Events Preclinical Australia
MORE ON THIS TOPIC
Stagflation, economic slow down or recession while inflation high up, GDP growth decrease causing by unemployment concept, fearful businessman riding fall down economic graph with inflation high up.
Cardiovascular disease
AstraZeneca, Ionis slip as ATTR-CM drug fails Phase 3
July 9, 2026
 · 
3 min read
 · 
Tristan Manalac
Podcast
Vertex carries M&A uptick into H2, IPOs and VC raises also grow, FDA on pace despite turmoil
July 8, 2026
 · 
1 min read
 · 
Jef Akst
3d render of the pole vault crossbar on blue sky background
Obesity
Hengrui, Kailera’s oral GLP-1 clears late-stage bar in China but US results still pending
July 7, 2026
 · 
4 min read
 · 
Gabrielle Masson
Communication by thoughts
Psychedelics
Compass’ psilocybin depression drug works for the long haul
July 7, 2026
 · 
2 min read
 · 
Annalee Armstrong